Telehealth ADHD prescriptions in New Jersey: the 2026 rules

Whether an ADHD stimulant can be prescribed by video to someone in New Jersey depends on two layers of law: a New Jersey statute that changed twice in 2026, and a federal rule that is temporary and dated. This article gives the position as of October 19, 2026, how New Jersey got here, what is unknown about 2027, and what a patient can do now.

The position as of October 2026

Both layers apply at once. A New Jersey prescriber must meet the state rule and the federal rule, so whichever is stricter on a given point controls.

How New Jersey got here: the 2026 timeline

1. March 2020 to February 2026. During the COVID-19 emergency, state waivers let prescribers treat patients with Schedule II drugs by telemedicine without a prior in-person visit.
2. January 16, 2026. Executive Order 415 ended the emergency, effective February 16, 2026.
3. February 16, 2026, 5:00 pm. The waivers expired.
4. February 17, 2026. The underlying statute applied again: no Schedule II prescription to a new patient by telehealth before an initial in-person visit, then an in-person visit every three months.
5. March 9, 2026. The Division of Consumer Affairs issued modified guidance. Patients already treated during the emergency could continue without an in-person visit through May 16, 2026.
6. July 8, 2026. P.L.2026, c.40 (A4852) was approved and took effect immediately. It created a separate route for adults on Schedule II stimulants.

Anything that says New Jersey requires an in-person visit every three months for adult ADHD stimulants, or bans telehealth stimulant prescribing, describes February to July 2026 and is out of date.

What P.L.2026, c.40 says, step by step

The adult stimulant paragraph is short. In plain terms:

• First examination. It may be in person or by telehealth, "as provided by regulation."
• Within 30 days. If the first examination was by telehealth, an in-person visit is required within 30 days of it.
• Every three months. A visit or contact is required every three months, and it may be in person or by telehealth.
• Once a year. At least one in-person visit is required each year for as long as the stimulant is prescribed.
• Video, not phone. Schedule II prescribing by telehealth requires interactive, real-time, two-way audio and visual technology. An audio-only call does not qualify.
• Same standard of care. The prescriber must meet the standard that applies in person.

The same law keeps the stricter general rule for other Schedule II drugs and lists exceptions for patients in active cancer treatment, hospice or palliative care, long-term care residents, care under the Medical Aid in Dying for the Terminally Ill Act, and medications for substance use disorder. For patients under 18, the in-person requirement does not apply to stimulants if a parent or guardian gives written consent. The practice treats adults only, so that exception does not affect its patients.

Elsewhere in the statute, a provider may not prescribe based solely on answers to an online static questionnaire. That is one reason a real evaluation matters. See online ADHD diagnosis in New Jersey.

Where you are during the visit decides which rules apply

New Jersey's telehealth statute requires a provider to be validly licensed to provide services in New Jersey and to remain subject to New Jersey's licensing board. What counts is where the patient is physically located during the visit. A New Jersey resident on a video call from their workplace in Manhattan is a patient located in New York for that visit. A New York resident on a call from a house in Montclair is a patient located in New Jersey.

For people who cross the Hudson, the details are in living in New Jersey, getting ADHD care in New York and the New York side in telehealth ADHD prescriptions in New York.

The federal layer and 2027

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 sets the federal default: no remote prescribing of a controlled substance without at least one in-person medical evaluation, unless an exception applies. The DEA and the Department of Health and Human Services have waived that requirement since the pandemic. The current document, the Fourth Temporary Extension, runs from January 1 through December 31, 2026 and covers audio-video encounters for Schedule II to V medications.

What is known about 2027:

• As of October 19, 2026, no fifth extension had been published in the Federal Register.
• A final rule on special registrations for telemedicine (RIN 1117-AB40) has been at the White House Office of Information and Regulatory Affairs since August 25, 2026 and is listed as pending review.
• Its text is not public. Nobody outside government can say how it treats Schedule II stimulants or when it takes effect.

If the federal flexibilities ended with nothing to replace them, the federal in-person requirement would apply before a first remote prescription, which would be stricter than New Jersey's 30-day window. That is a possibility, not a forecast.

Open questions in New Jersey

A July 16, 2026 law firm analysis of the new statute listed several points the text does not settle, including how the new schedule applies to patients already on stimulants and whether the Division of Consumer Affairs or the licensing boards will issue regulations or guidance. Whether such guidance has been issued since July 8 could not be confirmed as of October 2026.

Other bills are pending. For example, Senate Bill S4210, introduced May 11, 2026, would require an initial in-person examination for adult ADHD stimulants and then follow-up contacts every six months. An introduced bill is not law, and its status could not be confirmed. P.L.2026, c.40 is the law in force.

What to do now

1. Plan the in-person visit early. If your first examination is by video while you are in New Jersey, the in-person visit is due within 30 days. Ask where and when it will happen before you start.
2. Put the yearly in-person visit on your calendar. Missing it can interrupt prescriptions.
3. Be consistent about location. Tell the office where you will be for each video visit. A visit from New Jersey is governed by New Jersey law.
4. Use a device with a camera. A phone call does not meet the Schedule II video requirement.
5. Watch for the December 31 deadline. Check back in December, when the federal position for 2027 should be clearer.

Dr. Shershow is licensed in New York and New Jersey, and the office will explain how visits are arranged for patients located in New Jersey. The appointments and telehealth page has the current details. Supply limits and refill rules are covered separately in New Jersey's rules for ADHD stimulant prescriptions.